Download Unicorn Signals App

Powered By EquityPandit
Latest News

Lupin launches Solosec in US

Equitypandit_Lupin

Lupin has launched specialty drug Solosec in US. It is an antimicrobial agent for treating gynecologic infection, among adult women in US.

Last year in September, it had received an approval from USFDA. It’s the first antibiotic pill in the market to treat bacterial vaginosis (BV), which is the most common vaginal infection in the US among women of childbearing age.

Further, the drug is eligible for at least 10 years of marketing exclusivity in US and it is a single dose oral regimen.

Read EquityPandit’s Technical Analysis of Lupin 

Get Daily Prediction & Stocks Tips On Your Mobile